On the other hand, these results proved that the expression of PEPT1 in HCC cells, and the Doxorubicin-tripeptide conjugate can indeed be transported into the liver cancer cells by PEPT1 to play a anti-tumor action simultaneously. Here, SLC15A1 is linked to liver cancer.